Literature DB >> 17764959

Substrate specificity of prostate-specific membrane antigen.

Marc O Anderson1, Lisa Y Wu, Nicholas M Santiago, Jamie M Moser, Jennifer A Rowley, Erin S D Bolstad, Clifford E Berkman.   

Abstract

A series of putative dipeptide substrates of prostate-specific membrane antigen (PSMA) was prepared that explored alpha- and beta/gamma-linked acidic residues at the P1 position and various chromophores at the P2 position, while keeping the P1' residue constant as L-Glu. Four chromophores were examined, including 4-phenylazobenzoyl, 1-pyrenebutyryl, 9-anthracenylcarboxyl-gamma-aminobutyryl, and 4-nitrophenylbutyryl. When evaluating these chromophores, it was found that a substrate containing 4-phenylazobenzoyl at the P2 position was consumed most efficiently. Substitution at the P1 position with acidic residues showed that only gamma-linked L-Glu and D-Glu were recognized by the enzyme, with the former being more readily proteolyzed. Lastly, binding modes of endogenous substrates and our best synthetic substrate (4-phenylazobenzoyl-Glu-gamma-Glu) were proposed by computational docking studies into an X-ray crystal structure of the PSMA extracellular domain.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17764959      PMCID: PMC2014784          DOI: 10.1016/j.bmc.2007.08.006

Source DB:  PubMed          Journal:  Bioorg Med Chem        ISSN: 0968-0896            Impact factor:   3.641


  24 in total

1.  Characterization of the enzymatic activity of PSM: comparison with brain NAALADase.

Authors:  C W Tiffany; R G Lapidus; A Merion; D C Calvin; B S Slusher
Journal:  Prostate       Date:  1999-04-01       Impact factor: 4.104

Review 2.  A unique folate hydrolase, prostate-specific membrane antigen (PSMA): a target for immunotherapy?

Authors:  J Tasch; M Gong; M Sadelain; W D Heston
Journal:  Crit Rev Immunol       Date:  2001       Impact factor: 2.214

3.  Substrate specificity, inhibition and enzymological analysis of recombinant human glutamate carboxypeptidase II.

Authors:  Cyril Barinka; Markéta Rinnová; Pavel Sácha; Camilo Rojas; Pavel Majer; Barbara S Slusher; Jan Konvalinka
Journal:  J Neurochem       Date:  2002-02       Impact factor: 5.372

4.  Metastatic renal cell carcinoma neovasculature expresses prostate-specific membrane antigen.

Authors:  S S Chang; V E Reuter; W D Heston; P B Gaudin
Journal:  Urology       Date:  2001-04       Impact factor: 2.649

5.  Prostate-specific membrane antigen is produced in tumor-associated neovasculature.

Authors:  S S Chang; D S O'Keefe; D J Bacich; V E Reuter; W D Heston; P B Gaudin
Journal:  Clin Cancer Res       Date:  1999-10       Impact factor: 12.531

Review 6.  Ins and outs of clinical trials with peptide-based vaccines.

Authors:  Rachel B Salit; W Martin Kast; Markwin P Velders
Journal:  Front Biosci       Date:  2002-05-01

7.  Cloning, expression, genomic localization, and enzymatic activities of the mouse homolog of prostate-specific membrane antigen/NAALADase/folate hydrolase.

Authors:  D J Bacich; J T Pinto; W P Tong; W D Heston
Journal:  Mamm Genome       Date:  2001-02       Impact factor: 2.957

Review 8.  Omeprazole/Antacid-powder suspension-Santarus: omeprazole/sodium bicarbonate powder-Santarus, SAN 05.

Authors: 
Journal:  Drugs R D       Date:  2004

9.  Molecular characterization of human brain N-acetylated alpha-linked acidic dipeptidase (NAALADase).

Authors:  R Luthi-Carter; A K Barczak; H Speno; J T Coyle
Journal:  J Pharmacol Exp Ther       Date:  1998-08       Impact factor: 4.030

10.  Prostate-specific membrane antigen: a novel folate hydrolase in human prostatic carcinoma cells.

Authors:  J T Pinto; B P Suffoletto; T M Berzin; C H Qiao; S Lin; W P Tong; F May; B Mukherjee; W D Heston
Journal:  Clin Cancer Res       Date:  1996-09       Impact factor: 12.531

View more
  20 in total

Review 1.  GCPII imaging and cancer.

Authors:  C A Foss; R C Mease; S Y Cho; H J Kim; M G Pomper
Journal:  Curr Med Chem       Date:  2012       Impact factor: 4.530

Review 2.  PET imaging in prostate cancer: focus on prostate-specific membrane antigen.

Authors:  Ronnie C Mease; Catherine A Foss; Martin G Pomper
Journal:  Curr Top Med Chem       Date:  2013       Impact factor: 3.295

3.  Biochemical characterization of prostate-specific membrane antigen from canine prostate carcinoma cells.

Authors:  Lisa Y Wu; Jacqueline M Johnson; Jessica K Simmons; Desiree E Mendes; Jonathan J Geruntho; Tiancheng Liu; Wessel P Dirksen; Thomas J Rosol; William C Davis; Clifford E Berkman
Journal:  Prostate       Date:  2014-01-21       Impact factor: 4.104

4.  N-substituted glutamyl sulfonamides as inhibitors of glutamate carboxypeptidase II (GCP2).

Authors:  Brian R Blank; Pinar Alayoglu; William Engen; Joseph K Choi; Clifford E Berkman; Marc O Anderson
Journal:  Chem Biol Drug Des       Date:  2011-02-22       Impact factor: 2.817

5.  A high-affinity [(18)F]-labeled phosphoramidate peptidomimetic PSMA-targeted inhibitor for PET imaging of prostate cancer.

Authors:  Tanushree Ganguly; Shorouk Dannoon; Mark R Hopkins; Stephanie Murphy; Hendry Cahaya; Joseph E Blecha; Salma Jivan; Christopher R Drake; Cyril Barinka; Ella F Jones; Henry F VanBrocklin; Clifford E Berkman
Journal:  Nucl Med Biol       Date:  2015-06-09       Impact factor: 2.408

6.  In vitro targeted photodynamic therapy with a pyropheophorbide--a conjugated inhibitor of prostate-specific membrane antigen.

Authors:  Tiancheng Liu; Lisa Y Wu; Joseph K Choi; Clifford E Berkman
Journal:  Prostate       Date:  2009-05-01       Impact factor: 4.104

7.  PSMA-targeted SPECT agents: mode of binding effect on in vitro performance.

Authors:  Jessie R Nedrow-Byers; Adam L Moore; Tanushree Ganguly; Mark R Hopkins; Melody D Fulton; Paul D Benny; Clifford E Berkman
Journal:  Prostate       Date:  2012-08-21       Impact factor: 4.104

8.  Structural basis of interactions between human glutamate carboxypeptidase II and its substrate analogs.

Authors:  Cyril Barinka; Klara Hlouchova; Miroslava Rovenska; Pavel Majer; Miroslawa Dauter; Niyada Hin; Yao-Sen Ko; Takashi Tsukamoto; Barbara S Slusher; Jan Konvalinka; Jacek Lubkowski
Journal:  J Mol Biol       Date:  2008-01-05       Impact factor: 5.469

Review 9.  Prostate-specific membrane antigen as a target for cancer imaging and therapy.

Authors:  A P Kiess; S R Banerjee; R C Mease; S P Rowe; A Rao; C A Foss; Y Chen; X Yang; S Y Cho; S Nimmagadda; M G Pomper
Journal:  Q J Nucl Med Mol Imaging       Date:  2015-07-24       Impact factor: 2.346

10.  Structure-Activity Relationship of (18)F-Labeled Phosphoramidate Peptidomimetic Prostate-Specific Membrane Antigen (PSMA)-Targeted Inhibitor Analogues for PET Imaging of Prostate Cancer.

Authors:  Shorouk Dannoon; Tanushree Ganguly; Hendry Cahaya; Jonathan J Geruntho; Matthew S Galliher; Sophia K Beyer; Cindy J Choy; Mark R Hopkins; Melanie Regan; Joseph E Blecha; Lubica Skultetyova; Christopher R Drake; Salma Jivan; Cyril Barinka; Ella F Jones; Clifford E Berkman; Henry F VanBrocklin
Journal:  J Med Chem       Date:  2016-06-13       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.